Stock Message Board http://investorshangout.com/search?q=ALXN&...mp;yt1=Go!
Last Updated: Sunday, March 30, 2014 8:19:25 PM
Alexion Pharmaceuticals, Inc. ALXN Current Price and Quotes
Last Price 149.42
Previous Close 151.10 Open 152.00
Daily Range 155.76 - 149.34 52wk Range 185.43 - 87.01
Volume 2,331,361 Dividend N/A
Average Vol (3m) 1,724,438 Yield N/A
Alexion Pharmaceuticals, Inc. ALXN
Company Information
352 Knotter Drive
Cheshire, CT 06410
Phone: (203) 272-2596
Alexion Pharmaceuticals, Inc. ALXN
Not Available
Alexion Pharmaceuticals, Inc. ALXN
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Dec 31, 2013 10-K
CIK 0000899866
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Alexion Pharmaceuticals, Inc. ALXN
ALXN Security Details
Share Structure
Market Value1 $34,675,708,305 a/o Mar 28, 2014
Shares Outstanding 197,830,376 a/o Feb 03, 2014
Float Not Available
Authorized Shares Not Available
Par Value 0.0001
Shareholders
Shareholders of Record 415 a/o Feb 29, 2008
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.00) May 23, 2011 May 02, 2011 May 20, 2011
Dividend (0.00) * May 02, 2011
Security Notes
New Issue=2-96 2,200,000 shs at $8.25 by Josephthal Lyon & Ross Inc.
Capital Change=shs increased by 2 for 1 split Ex-date=08/25/2008. Rec date=08/12/2008. Pay date=08/22/2008.
Capital Change=shs increased by 2 for 1 split. Ex-date=05/23/2011. Rec date=05/02/2011. Pay date=05/20/2011.
Short Selling Data
Short Interest 5,288,144 (7.69%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)
Continental Stock Transfer & Trust Company
Alexion Pharmaceuticals, Inc. ALXN Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,551,346 1,134,114 783,431 540,957
Cost of Revenue 177,556 72,837 93,140 64,437
Gross Profit 1,373,790 1,061,277 690,291 476,520
Operating Expenses
Research and Development 317,093 222,732 137,421 98,394
Sales, General and Admin. 489,720 384,678 308,176 226,766
Non-Recurring Items 38,550 49,112 13,486 722
Other 417 417 382 -
Operating Income 528,010 404,338 230,826 150,638
Income From Continuing Operations
Add'l Income/Expense Items 2,371 630 (370) (923)
Earnings Before Interest and Tax 530,381 404,968 230,456 149,715
Interest Expense 4,112 7,402 788 704
Earnings Before Tax 526,269 397,566 229,668 149,011
Income Tax 273,374 142,744 54,353 51,981
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 252,895 254,822 175,315 97,030
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 252,895 254,822 175,315 97,030
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 252,895 254,822 175,315 97,030
Alexion Pharmaceuticals, Inc. ALXN Recent News
Mar 26, 2014 The Zacks Analyst Blog Highlights: IShares NASDAQ Biotechnology ETF, Gilead, Alexion Pharmaceuticals, Amgen and Myriad Genetics
Mar 26, 2014 Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic
Mar 25, 2014 Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharma, Incyte, and Aastrom Biosciences
Mar 25, 2014 The Zacks Analyst Blog Highlights:Bristol-Myers Squibb, Pfizer, Alexion Pharmaceuticals, Gilead Sciences and AGCO
Mar 14, 2014 Conference Schedules, Upcoming Marathon Applications, Revised Guidance, and Acquisitions - Analyst Notes on Celgene, Medtronic, Alexion, Quest Diagnostics, and Illumina
Mar 10, 2014 Alexion Revises Upward 2014 Financial Guidance for Revenues and non-GAAP EPS
Mar 5, 2014 Collaborations, Conferences, and Recognitions - Analyst Notes on Illumina, Alexion, Medtronic, Sirona, and NPS Pharmaceuticals
Mar 5, 2014 Alexion to Present at the Barclays Global Healthcare Conference
Mar 5, 2014 Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver
Mar 4, 2014 The Zacks Analyst Blog Highlights:Sanofi, Alnylam Pharmaceuticals, Alexion Pharmaceuticals, Gilead Sciences and Amgen
1
2
3
next >
ALXN Alexion Pharmaceuticals, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=ALXN&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ALXN/quote
Stock Chart http://www.otcmarkets.com/stock/ALXN/chart
Company Info http://www.otcmarkets.com/stock/ALXN/company-info
Recent News http://www.otcmarkets.com/stock/ALXN/news
Financials http://www.otcmarkets.com/stock/ALXN/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ALXN/filings
Short Sales http://www.otcmarkets.com/stock/ALXN/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ALXN/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ALXN/research
Summary http://finance.yahoo.com/q?s=ALXN
Historical Prices http://finance.yahoo.com/q/hp?s=ALXN+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ALXN
Basic Chart http://finance.yahoo.com/q/bc?s=ALXN+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ALXN+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ALXN+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ALXN+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ALXN+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ALXN+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ALXN+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ALXN+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ALXN+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ALXN+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ALXN
Balance Sheet http://finance.yahoo.com/q/bs?s=ALXN
Cash Flow http://finance.yahoo.com/q/cf?s=ALXN+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ALXN
Market Watch http://www.marketwatch.com/investing/stock/ALXN
Bloomberg http://www.bloomberg.com/quote/ALXN:US
Morningstar http://quotes.morningstar.com/stock/s?t=ALXN
Bussinessweek http://investing.businessweek.com/research/st...icker=ALXN
Barchart http://www.barchart.com/quotes/stocks/ALXN
OTC Short Report http://otcshortreport.com/index.php?index=ALXN
Investopedia http://www.investopedia.com/markets/stocks/ALXN/?wa=0